HER2 expression and testing practices vary across endometrial ovarian and cervical cancers while expanding clinical evidence is creating new opportunities and uncertainties for biomarkerinformed treatment This activity examines HER2 testing and HER2directed therapy in gynecologic cancers including interpretation of test results patient selection and sequencing considerations emerging data on HER2directed antibodydrug conjugates and multidisciplinary strategies for monitoring and managing treatmentrelated toxicities
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12001 Sunrise Valley Drive
Pricing
98% of listed courses are free
294 of a sample of 300 are free · 531 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Live
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
WhenNov 2, 2026
-
Clinical Care Options, LLC (dba Decera Clinical Education) Precision in Practice: Implementing HER2 Testing and HER2-Directed Therapy in Gynecologic Cancers
-
Clinical Care Options, LLC (dba Decera Clinical Education) The HER2 Horizon: The Next Era of HER2 Targeted Treatment in GI Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) Integrating HER2-Directed ADCs Across Early and Metastatic Breast Cancer: Practical Strategies for Testing, Sequencing, and Patient-Centered Care
-
PRIME Education, Inc. (PRIME®) Biomarker to Bedside: Practical Approaches to HER2 Testing and Targeted Treatment in Gynecologic Cancers
-
Efficient CME, CME Outfitters, LLC Where s the Consensus: Expert Practices for Biomarker-Guided Management of Advanced Endometrial Cancer
-
PVI, PeerView Institute for Medical Education Precision-Guided Interventions in HER2+ GI Tumors Expert Perspectives on Operationalizing The Latest Evidence on Antibody-Drug Conjugates For Advanced Disease
